IRIS
RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.555
AS - Asia 4.244
NA - Nord America 3.755
SA - Sud America 890
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 20.496
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.322
US - Stati Uniti d'America 3.653
SG - Singapore 1.571
IE - Irlanda 1.108
CN - Cina 876
IT - Italia 807
HK - Hong Kong 746
BR - Brasile 735
GB - Regno Unito 365
DE - Germania 302
KR - Corea 286
VN - Vietnam 271
UA - Ucraina 167
IN - India 148
JP - Giappone 99
FR - Francia 97
GR - Grecia 82
FI - Finlandia 68
AR - Argentina 53
TR - Turchia 53
CA - Canada 43
SE - Svezia 42
MX - Messico 39
NL - Olanda 36
EC - Ecuador 27
BD - Bangladesh 26
ID - Indonesia 25
RO - Romania 24
AT - Austria 22
PK - Pakistan 22
BE - Belgio 21
PL - Polonia 19
CO - Colombia 18
CZ - Repubblica Ceca 16
ES - Italia 16
VE - Venezuela 15
EG - Egitto 14
IR - Iran 14
IQ - Iraq 13
ZA - Sudafrica 12
LT - Lituania 11
AZ - Azerbaigian 10
CL - Cile 10
PE - Perù 10
PY - Paraguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
TW - Taiwan 7
UY - Uruguay 7
JO - Giordania 6
KZ - Kazakistan 6
BO - Bolivia 5
IL - Israele 5
KG - Kirghizistan 5
MY - Malesia 5
NP - Nepal 5
SA - Arabia Saudita 5
CH - Svizzera 4
CR - Costa Rica 4
PT - Portogallo 4
DK - Danimarca 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
MK - Macedonia 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
TJ - Tagikistan 2
UG - Uganda 2
AL - Albania 1
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
KW - Kuwait 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
Totale 20.491
Salva come PNG Salva come JPEG
Città #
Moscow 2.797
Dublin 1.096
Hong Kong 745
Singapore 671
Santa Clara 611
Chandler 399
Jacksonville 290
Seoul 285
The Dalles 195
Hefei 164
New York 159
Princeton 153
Ashburn 152
Roxbury 148
Naples 143
Beijing 122
Ho Chi Minh City 106
Bremen 98
Bengaluru 94
Dallas 93
Caserta 83
Cambridge 82
Medford 72
São Paulo 70
Munich 63
Ann Arbor 58
Hanoi 50
Wilmington 49
Des Moines 46
Falkenstein 36
Los Angeles 31
Boardman 30
Napoli 29
Nanjing 28
Redwood City 25
Woodbridge 25
Milan 23
Amsterdam 22
Helsinki 21
Nuremberg 21
Atlanta 20
Brussels 20
Jinan 20
Washington 20
Frankfurt am Main 18
London 18
Mountain View 18
Chicago 17
Haiphong 17
Belo Horizonte 15
Rio de Janeiro 15
Aversa 14
Brasília 14
Chennai 14
Da Nang 14
Houston 14
Shenyang 14
Tianjin 14
Turku 14
Brooklyn 13
Salvador 13
Warsaw 13
Curitiba 12
Florence 12
Guayaquil 12
Lahore 12
Porto Alegre 12
Salerno 12
Boston 11
Giugliano In Campania 11
Norwalk 11
Changsha 10
Monserrato 10
Shanghai 10
Vienna 10
Hangzhou 9
Istanbul 9
Montreal 9
Rome 9
Stockholm 9
Taizhou 9
Timisoara 9
Vitulazio 9
Zhengzhou 9
Baku 8
Campinas 8
Columbus 8
Dhaka 8
Guarulhos 8
Marano Di Napoli 8
Mexico City 8
San Mateo 8
Seattle 8
Shenzhen 8
Tokyo 8
Toronto 8
Volta Redonda 8
Bogotá 7
Guastalla 7
Haikou 7
Totale 10.085
Salva come PNG Salva come JPEG
Nome #
Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria 194
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 190
A genic and epigenetic combination therapy for liver cancer 173
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 171
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease 171
Bartter syndrome 168
What changed in the Italian internal medicine and geriatric wards during the lockdown 167
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 159
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 156
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 156
Chronic HCV infection and neurological and psychiatric disorders: an overview. 152
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 151
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: Identification of eleven novel pathogenic sequence variants 151
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 151
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 147
Sonoporation by microbubbles as gene therapy approach against liver cancer 147
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 147
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 146
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 144
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience. 143
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 142
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 141
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 139
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 139
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 138
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 138
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 134
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 133
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 133
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 133
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 133
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 132
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 131
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 131
Editorial – Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment 131
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 131
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 130
[Next Generation Sequencing and ADPKD] 129
Diagnostic performance of LI-RADS in adult patients with rare hepatic tumors 129
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 128
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 127
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 127
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 126
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 126
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 124
Spirometry in elderly laryngectomized patients: A feasibility study 124
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 124
Chronic Hepatitis C Virus Infection and Depression. 124
Predictors of early and late hepatocellular carcinoma recurrence 123
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 122
Cardiovascular benefits from gliflozins: Effects on endothelial function 122
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 121
HCV-related steatosis and risk of atherosclerosis 121
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 121
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 121
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 119
HCC and molecular targeting therapies: Back to the future 119
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 119
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 118
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 117
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 117
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 116
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 116
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 116
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 115
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 115
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 115
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 113
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 112
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 112
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 110
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 110
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals 110
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 110
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 110
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 109
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 108
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 108
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 107
Association between the spread of COVID-19 and weather-climatic parameters 107
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 106
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 106
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 106
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 102
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 102
Chronic HCV infection is a risk factor of ischemic stroke 102
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 102
Renal handling of uric acid 101
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 101
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 101
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 100
Patho-physiology of renal dysfunction in Bardet-Biedl Syndrome 100
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 100
Antibiotic use and associated factors in a large sample of hospitalised older people 100
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study 100
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 100
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 99
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 99
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 99
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 99
Totale 12.565
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021389 0 0 0 0 0 35 147 42 14 37 89 25
2021/2022964 25 4 16 27 297 20 15 23 71 64 84 318
2022/20231.940 179 61 55 86 238 121 6 98 993 21 35 47
2023/20241.111 84 30 55 64 306 169 36 38 21 40 92 176
2024/20253.379 29 65 18 59 526 399 482 309 513 402 320 257
2025/202611.792 626 721 714 670 1.299 7.762 0 0 0 0 0 0
Totale 20.959